210 related articles for article (PubMed ID: 30900384)
1. Knockdown of KLF5 promotes cisplatin-induced cell apoptosis via regulating DNA damage checkpoint proteins in non-small cell lung cancer.
Zhang H; Shao F; Guo W; Gao Y; He J
Thorac Cancer; 2019 May; 10(5):1069-1077. PubMed ID: 30900384
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
3. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α.
Li X; Liu X; Xu Y; Liu J; Xie M; Ni W; Chen S
Int J Oncol; 2014 Oct; 45(4):1507-14. PubMed ID: 25051115
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PANDAR promoted radiation and cisplatin-induced DNA damage repair through ATR/CHK1 in NSCLC.
Zhao S; Yu N; Wang H; Wan Z; Diao C; Chen Y; Liu T; Yang Y; Gao F; Bai C; Cao K; Cai J
J Gene Med; 2023 Dec; 25(12):e3565. PubMed ID: 37460393
[TBL] [Abstract][Full Text] [Related]
6. Fbxo6 confers drug-sensitization to cisplatin via inhibiting the activation of Chk1 in non-small cell lung cancer.
Cai L; Li J; Zhao J; Guo Y; Xie M; Zhang X; Wang L; Tian H; Li A; Li Q; Miao Y
FEBS Lett; 2019 Jul; 593(14):1827-1836. PubMed ID: 31140586
[TBL] [Abstract][Full Text] [Related]
7. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
9. Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway.
Mei Y; Liu YB; Hu DL; Zhou HH
Int J Biol Sci; 2018; 14(13):1859-1872. PubMed ID: 30443189
[TBL] [Abstract][Full Text] [Related]
10. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
12. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
13. ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response.
Shen H; Wang L; Zhang J; Dong W; Zhang T; Ni Y; Cao H; Wang K; Li Y; Wang Y; Du J
Oncol Rep; 2017 Feb; 37(2):761-767. PubMed ID: 28035404
[TBL] [Abstract][Full Text] [Related]
14. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
[TBL] [Abstract][Full Text] [Related]
16. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
Meyer SE; Hasenstein JR; Baktula A; Velu CS; Xu Y; Wan H; Whitsett JA; Gilks CB; Grimes HL
Am J Pathol; 2010 Sep; 177(3):1503-13. PubMed ID: 20639455
[TBL] [Abstract][Full Text] [Related]
17. High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.
Chen X; Qian D; Cheng J; Guan Y; Zhang B; Ding X; Zeng J; Chen X; Er P; Zhang F; Zhao N; Chen X; Zhao L; Yuan Z; Pang Q; Wang P
Tumour Biol; 2016 Oct; 37(10):13489-13498. PubMed ID: 27465554
[TBL] [Abstract][Full Text] [Related]
18. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
19. Patchouli alcohol induces G
Liang CY; Chang KF; Huang YC; Huang XF; Sheu GT; Kuo CF; Hsiao CY; Tsai NM
Thorac Cancer; 2023 Jul; 14(21):2007-2017. PubMed ID: 37249164
[TBL] [Abstract][Full Text] [Related]
20. Krüppel-Like Factor 5 Promotes Epithelial Proliferation and DNA Damage Repair in the Intestine of Irradiated Mice.
Li M; Gu Y; Ma YC; Shang ZF; Wang C; Liu FJ; Cao JP; Wan HJ; Zhang XG
Int J Biol Sci; 2015; 11(12):1458-68. PubMed ID: 26681925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]